BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Roohani J, Keikha M. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned? World J Virol 2022; 11(6): 496-501 [PMID: 36483099 DOI: 10.5501/wjv.v11.i6.496]
URL: https://www.wjgnet.com/2220-3249/full/v11/i6/496.htm
Number Citing Articles
1
Can Peng, Xinyue Lv, Zhiqiang Zhang, Jianping Lin, Dongmei Li. The Recognition Pathway of the SARS-CoV-2 Spike Receptor-Binding Domain to Human Angiotensin-Converting Enzyme 2Molecules 2024; 29(8): 1875 doi: 10.3390/molecules29081875
2
Min Shen, Ping Ding, Guangxin Luan, Ting Du, Shanshan Deng. The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patientsFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1141274